1. Home
  2. TLSI
  3. TLSI News

Latest TriSalus Life Sciences Inc. (TLSI) News on November 25, 2025

TLSI

Business Wire

7 days ago

TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™

TLSI

GuruFocus.com

12 days ago

TriSalus Life Sciences Inc (TLSI) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ...

TriSalus (TLSI) Q3 2025 Earnings Call Transcript
TLSI

Motley Fool

12 days ago

TriSalus (TLSI) Q3 2025 Earnings Call Transcript

TriSalus Life Sciences, Inc. (TLSI) Reports Q3 Loss, Tops Revenue Estimates
TLSI

Zacks

12 days ago

TriSalus Life Sciences, Inc. (TLSI) Reports Q3 Loss, Tops Revenue Estimates

TLSI

MT Newswires

12 days ago

TriSalus Life Sciences Q3 Loss Widens, Revenue Rises

TLSI

Business Wire

12 days ago

TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance

TriSalus Life Sciences Inc (TLSI) Q3 2025 Earnings Report Preview: What To Expect
TLSI

GuruFocus.com

13 days ago

TriSalus Life Sciences Inc (TLSI) Q3 2025 Earnings Report Preview: What To Expect

Rockwell Medical (RMTI) Reports Q3 Loss, Lags Revenue Estimates
TLSI

Zacks

13 days ago

Rockwell Medical (RMTI) Reports Q3 Loss, Lags Revenue Estimates

TLSI

Business Wire

14 days ago

TriSalus Life Sciences to Participate in Upcoming Investor Conferences

TLSI

Business Wire

15 days ago

TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025

ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates
TLSI

Zacks

19 days ago

ICU Medical (ICUI) Surpasses Q3 Earnings and Revenue Estimates

biote Corp. (BTMD) Tops Q3 Earnings and Revenue Estimates
TLSI

Zacks

20 days ago

biote Corp. (BTMD) Tops Q3 Earnings and Revenue Estimates

TLSI

Business Wire

a month ago

TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call

TLSI

Business Wire

5 months ago

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure

TLSI

Business Wire

6 months ago

TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System

TLSI

Business Wire

6 months ago

TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience

TLSI

GuruFocus.com

6 months ago

TriSalus Life Sciences Inc (TLSI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...

TLSI

Business Wire

6 months ago

TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance

TLSI

Business Wire

6 months ago

TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call

TLSI

Business Wire

7 months ago

TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results

TLSI

Business Wire

8 months ago

TriSalus Life Sciences Reports Q4 and Full Year 2024 Financial Results and Provides Business Update

TLSI

Business Wire

8 months ago

TriSalus Life Sciences Announces New CMS HCPCS Code for TriNav® Infusion System Mapping

TLSI

Business Wire

9 months ago

TriSalus Life Sciences® Announces That Its Researchers Received Two JVIR Top Paper Awards for the Publication of "Intra-arterial Pressure-Enabled Drug Delivery™ Significantly Increases Penetration of Glass Microspheres in a Porcine Liver Tumor Model"

TLSI

Business Wire

10 months ago

TriSalus Life Sciences Announces Key Appointments to Board of Directors

TLSI

Business Wire

10 months ago

TriSalus Life Sciences Announces Drawdown of $10 Million Tranche Under Credit Agreement with OrbiMed

TLSI

Argus Research

10 months ago

Daily – Vickers Top Buyers & Sellers for 02/03/2025

TLSI

Argus Research

10 months ago

Daily – Vickers Top Buyers & Sellers for 01/30/2025

TLSI

Business Wire

10 months ago

TriSalus Life Sciences Announces Preliminary Q4 and Full Year Unaudited 2024 Financial Results and Conference Call

TriSalus Life Sciences announces publication of pre-clinical data
TLSI

TipRanks

10 months ago

TriSalus Life Sciences announces publication of pre-clinical data

TLSI

Business Wire

a year ago

TriSalus Life Sciences® Announces Publication of Pre-Clinical Data Demonstrating Improved Delivery of Embospheres® to Liver Tumors using Pressure-Enabled Drug Delivery™ (PEDD™) via the TriNav® Infusion System

TLSI

Business Wire

a year ago

TriSalus Announces Leadership Changes

TLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 12/10/2024

TLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 12/09/2024

TLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 12/06/2024

TLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 12/05/2024

TLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 12/04/2024

TLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 12/03/2024

TLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 12/02/2024

TLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 11/29/2024

TLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 11/27/2024

TLSI

Argus Research

a year ago

Daily – Vickers Top Insider Picks for 11/26/2024

TLSI

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 11/25/2024

TriSalus Reports Q3 2024 Financial Results and Provides Business Update
TLSI

Business Wire

a year ago

TriSalus Reports Q3 2024 Financial Results and Provides Business Update

TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Preview: What To Look For
TLSI

GuruFocus.com

a year ago

TriSalus Life Sciences Inc (TLSI) Q3 2024 Earnings Report Preview: What To Look For

TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer
TLSI

Business Wire

a year ago

TriSalus Life Sciences® Forms Strategic Partnership with Geo-Med, LLC to Expand Access of the TriNav® Infusion System to U.S. Veterans with Liver Cancer

TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment
TLSI

Business Wire

a year ago

TriSalus Life Sciences Launches TriNav® LV Infusion System and TriGuide™ Guiding Catheters, Expanding Portfolio of PEDD™ Devices for Improved Tumor Treatment

TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call
TLSI

Business Wire

a year ago

TriSalus Life Sciences to Host Third Quarter 2024 Financial Results Conference Call

TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
TLSI

Business Wire

a year ago

TriSalus Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit

TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board
TLSI

Business Wire

a year ago

TriSalus Life Sciences Announces Appointment of Riad Salem, M.D., to its Scientific Advisory Board

TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System
TLSI

Business Wire

a year ago

TriSalus Announces Journal of Vascular and Interventional Radiology Publication of Data that Demonstrate Improved Therapeutic Delivery of Glass Microspheres to Solid Tumors With PEDD™ Method via the TriNav® Infusion System

TLSI

GuruFocus.com

a year ago

TriSalus Life Sciences Inc (TLSI) CEO Buys Shares

TriSalus Reports Q2 2024 Financial Results and Business Update
TLSI

Business Wire

a year ago

TriSalus Reports Q2 2024 Financial Results and Business Update

TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call
TLSI

Business Wire

a year ago

TriSalus Life Sciences to Host Second Quarter 2024 Financial Results Conference Call

TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation
TLSI

Business Wire

a year ago

TriSalus Life Sciences Announces Completion of Exchange Offer and Consent Solicitation

TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants
TLSI

Business Wire

a year ago

TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants

TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma at 2024 ASCO Annual Meeting
TLSI

Business Wire

a year ago

TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma at 2024 ASCO Annual Meeting

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants
TLSI

Business Wire

2 years ago

TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

TriSalus Reports Q1 2024 Financial Results and Business Update
TLSI

Business Wire

2 years ago

TriSalus Reports Q1 2024 Financial Results and Business Update

TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors
TLSI

Business Wire

2 years ago

TriSalus Life Sciences Appoints Liselotte Hyveled to its Board of Directors

TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call
TLSI

Business Wire

2 years ago

TriSalus Life Sciences to Host First Quarter 2024 Financial Results Conference Call

TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives
TLSI

Business Wire

2 years ago

TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNav® Infusion System Growth Initiatives

TriSalus Life Sciences Inc (TLSI) Q4 and Full Year 2023 Earnings: Revenue Growth Amidst Late ...
TLSI

GuruFocus.com

2 years ago

TriSalus Life Sciences Inc (TLSI) Q4 and Full Year 2023 Earnings: Revenue Growth Amidst Late ...

TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update
TLSI

Business Wire

2 years ago

TriSalus Reports Q4 and Full Year 2023 Financial Results and Business Update

TriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific Meeting
TLSI

Business Wire

2 years ago

TriSalus Life Sciences Technology Featured in Two Presentations at the Society of Interventional Radiology Annual Scientific Meeting

TriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting
TLSI

Business Wire

2 years ago

TriSalus Life Sciences Announces Oral Presentations at the Upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting

TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Results
TLSI

Business Wire

2 years ago

TriSalus Life Sciences Announces Q4 Conference Call and Preliminary and Unaudited Q4 and Full Year 2023 Financial Results

TriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for "Nelitolimod" as the Nonproprietary Drug Name for SD-101
TLSI

Business Wire

2 years ago

TriSalus Life Sciences Receives Approval from the World Health Organization and the American Medical Association’s Adopted Name Council for "Nelitolimod" as the Nonproprietary Drug Name for SD-101

TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors
TLSI

Business Wire

2 years ago

TriSalus Life Sciences Announces Real-World Data Demonstrating the Ability of TriNav® to Successfully Treat Patients with Higher Disease Burden and to Improve Delivery of Therapeutics to Liver Tumors

Alerus (ALRS) Reports Q4 Earnings: What Key Metrics Have to Say
TLSI

Zacks

2 years ago

Alerus (ALRS) Reports Q4 Earnings: What Key Metrics Have to Say

TLSI

Business Wire

2 years ago

Franklin Templeton Fund Adviser, LLC Announces Distributions for the Month of February 2024

Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock
TLSI

GlobeNewswire

2 years ago

Esperion Announces Pricing of $85.1 Million Public Offering of Common Stock

Investing in BayCom (NASDAQ:BCML) three years ago would have delivered you a 45% gain
TLSI

Simply Wall St.

2 years ago

Investing in BayCom (NASDAQ:BCML) three years ago would have delivered you a 45% gain

Keep an Eye on these 3 Networking Stocks in a Thriving Industry
TLSI

Zacks

2 years ago

Keep an Eye on these 3 Networking Stocks in a Thriving Industry

Invesco Value Municipal Income Trust's Dividend Analysis
TLSI

GuruFocus.com

2 years ago

Invesco Value Municipal Income Trust's Dividend Analysis

Investing in Red Violet (NASDAQ:RDVT) five years ago would have delivered you a 155% gain
TLSI

Simply Wall St.

2 years ago

Investing in Red Violet (NASDAQ:RDVT) five years ago would have delivered you a 155% gain

red violet Announces Appointment of Bill Livek to Board of Directors
TLSI

GlobeNewswire

2 years ago

red violet Announces Appointment of Bill Livek to Board of Directors

ON24 to Participate in the Upcoming 26th Annual Needham Growth Conference
TLSI

Business Wire

2 years ago

ON24 to Participate in the Upcoming 26th Annual Needham Growth Conference

Raise a Toast to These 5 Consumer Discretionary Stocks in 2024
TLSI

Zacks

2 years ago

Raise a Toast to These 5 Consumer Discretionary Stocks in 2024

ON24 Named a Leader in 2023-2024 IDC MarketScape for Virtual Events Applications
TLSI

Business Wire

2 years ago

ON24 Named a Leader in 2023-2024 IDC MarketScape for Virtual Events Applications

TLSI

Business Wire

2 years ago

ClearBridge MLP and Midstream Total Return Fund Inc. Announces Unaudited Balance Sheet Information as of December 31, 2023

VALNEVA - Declaration of shares and voting rights: December 31, 2023
TLSI

GlobeNewswire

2 years ago

VALNEVA - Declaration of shares and voting rights: December 31, 2023

Cipher Mining Announces 60 MW Expansion of its Bear and Chief Joint Venture Data Centers and Purchase of 16,700 New Miners from Canaan Inc.
TLSI

GlobeNewswire

2 years ago

Cipher Mining Announces 60 MW Expansion of its Bear and Chief Joint Venture Data Centers and Purchase of 16,700 New Miners from Canaan Inc.

Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
TLSI

GlobeNewswire

2 years ago

Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

While institutions own 46% of Applied Optoelectronics, Inc. (NASDAQ:AAOI), retail investors are its largest shareholders with 49% ownership
TLSI

Simply Wall St.

2 years ago

While institutions own 46% of Applied Optoelectronics, Inc. (NASDAQ:AAOI), retail investors are its largest shareholders with 49% ownership

TLSI

Business Wire

2 years ago

ClearBridge MLP and Midstream Fund Inc., ClearBridge Energy Midstream Opportunity Fund Inc. and ClearBridge MLP and Midstream Fund Total Return Inc. Announce Plans for Tender Offers

red violet Announces Additional $5 Million Share Repurchase Authorization
TLSI

GlobeNewswire

2 years ago

red violet Announces Additional $5 Million Share Repurchase Authorization

Shareholders Should Be Pleased With The Aaron's Company, Inc.'s (NYSE:AAN) Price
TLSI

Simply Wall St.

2 years ago

Shareholders Should Be Pleased With The Aaron's Company, Inc.'s (NYSE:AAN) Price

MidWestOne (MOFG) Moves 7.9% Higher: Will This Strength Last?
TLSI

Zacks

2 years ago

MidWestOne (MOFG) Moves 7.9% Higher: Will This Strength Last?

Financial Institutions, Inc. (NASDAQ:FISI) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
TLSI

Simply Wall St.

2 years ago

Financial Institutions, Inc. (NASDAQ:FISI) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Financial Institutions, Inc. Announces Leadership Changes
TLSI

GlobeNewswire

2 years ago

Financial Institutions, Inc. Announces Leadership Changes

TLSI

Business Wire

2 years ago

ClearBridge MLP and Midstream Total Return Fund Inc. Announces Unaudited Balance Sheet Information as of November 30, 2023

New Found Intercepts 43 g/t Au Over 11.6m at Keats West
TLSI

Business Wire

2 years ago

New Found Intercepts 43 g/t Au Over 11.6m at Keats West

TLSI

PR Newswire

2 years ago

Royce Micro-Cap Trust, Inc. (NYSE-RMT) declares Fourth Quarter Common Stock Distribution of $0.22 Per Share

BayCom Corp Announces Cash Dividend
TLSI

Business Wire

2 years ago

BayCom Corp Announces Cash Dividend

MidWestOne Financial Group (NASDAQ:MOFG) Has Affirmed Its Dividend Of $0.2425
TLSI

Simply Wall St.

2 years ago

MidWestOne Financial Group (NASDAQ:MOFG) Has Affirmed Its Dividend Of $0.2425

TLSI

PR Newswire

2 years ago

Royce Micro-Cap Trust (NYSE: RMT) as of Oct 31, 2023

There's A Lot To Like About MidWestOne Financial Group's (NASDAQ:MOFG) Upcoming US$0.24 Dividend
TLSI

Simply Wall St.

2 years ago

There's A Lot To Like About MidWestOne Financial Group's (NASDAQ:MOFG) Upcoming US$0.24 Dividend

StealthGas Inc. (NASDAQ:GASS) Q3 2023 Earnings Call Transcript
TLSI

Insider Monkey

2 years ago

StealthGas Inc. (NASDAQ:GASS) Q3 2023 Earnings Call Transcript

TLSI

Associated Press Finance

2 years ago

StealthGas: Q3 Earnings Snapshot

STEALTHGAS INC. Reports Third Quarter and Nine Months 2023 Financial and Operating Results
TLSI

GlobeNewswire

2 years ago

STEALTHGAS INC. Reports Third Quarter and Nine Months 2023 Financial and Operating Results

Share on Social Networks: